The price-to-earnings ratio for Enterprise Products Partners L P (NYSE: EPD) is above average at 11.07x, Company’s 36-month beta value is 1.01.Analysts have differing opinions on the stock, with 11 analysts rating it as a “buy,” 11 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for EPD is 1.45B, and currently, short sellers hold a 1.06% ratio of that floaft. The average trading volume of EPD on October 22, 2024 was 4.11M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
EPD) stock’s latest price update
The stock price of Enterprise Products Partners L P (NYSE: EPD) has dropped by -0.62 compared to previous close of 29.18. Despite this, the company has seen a fall of -1.66% in its stock price over the last five trading days. globenewswire.com reported 2024-10-21 that Noom Med with Smart Rx, in partnership with Waltz Health, drives significant ROI for employers who wish to cover GLP-1s as a supplemental benefit such that the payer can choose the level of financial assistance they will provide Noom Weight with GLP-1 Rx delivers a proven obesity program and employee-pay access to affordable GLP-1s for employers who choose not to cover GLP-1s today NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, is tackling the problem of GLP-1 availability, accessibility and inflated costs head-on by launching two distinct enterprise solutions that reduce obesity management costs while enabling access to life-changing medications: Noom Med with Smart Rx in partnership with Waltz Health and Noom Weight with GLP-1 Rx. Both options support different budgets and organizational priorities to reduce GLP-1 medication costs and lower overall healthcare expenditures.
EPD’s Market Performance
Enterprise Products Partners L P (EPD) has experienced a -1.66% fall in stock performance for the past week, with a -1.09% drop in the past month, and a -3.30% drop in the past quarter. The volatility ratio for the week is 1.19%, and the volatility levels for the past 30 days are at 1.14% for EPD. The simple moving average for the past 20 days is -1.00% for EPD’s stock, with a 1.58% simple moving average for the past 200 days.
Analysts’ Opinion of EPD
Many brokerage firms have already submitted their reports for EPD stocks, with BofA Securities repeating the rating for EPD by listing it as a “Buy.” The predicted price for EPD in the upcoming period, according to BofA Securities is $35 based on the research report published on October 17, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see EPD reach a price target of $28. The rating they have provided for EPD stocks is “Neutral” according to the report published on October 06th, 2023.
EPD Trading at -0.72% from the 50-Day Moving Average
After a stumble in the market that brought EPD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.49% of loss for the given period.
Volatility was left at 1.14%, however, over the last 30 days, the volatility rate increased by 1.19%, as shares sank -1.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.01% upper at present.
During the last 5 trading sessions, EPD fell by -1.66%, which changed the moving average for the period of 200-days by +8.29% in comparison to the 20-day moving average, which settled at $29.29. In addition, Enterprise Products Partners L P saw 10.06% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EPD starting from TEAGUE AJ, who purchase 4,180 shares at the price of $29.35 back on Aug 27 ’24. After this action, TEAGUE AJ now owns 74,911 shares of Enterprise Products Partners L P, valued at $122,681 using the latest closing price.
TEAGUE AJ, the Co-Chief Executive Officer of Enterprise Products Partners L P, purchase 2,410 shares at $26.17 during a trade that took place back on Dec 19 ’23, which means that TEAGUE AJ is holding 6,060 shares at $63,076 based on the most recent closing price.
Stock Fundamentals for EPD
Current profitability levels for the company are sitting at:
- 0.12 for the present operating margin
- 0.13 for the gross margin
The net margin for Enterprise Products Partners L P stands at 0.11. The total capital return value is set at 0.12. Equity return is now at value 20.79, with 8.08 for asset returns.
Based on Enterprise Products Partners L P (EPD), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at 0.26. The debt to equity ratio resting at 1.09. The interest coverage ratio of the stock is 10.41.
Currently, EBITDA for the company is 8.81 billion with net debt to EBITDA at 3.51. When we switch over and look at the enterprise to sales, we see a ratio of 1.71. The receivables turnover for the company is 6.32for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.91.
Conclusion
In a nutshell, Enterprise Products Partners L P (EPD) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
